top of page

Sparian Biosciences

​

​

Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).

Press Release

NEW YORK, NY,  August 8th -- Sparian Biosciences Awarded $19 Million Five-Year NIH/NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development ...

Home

AEAr Agonists

MOR Agonist/ DOR Antagonists

Irreversible MOR Antagonists

Peripheral DOR Bitopic Agonists

Sigma Antagonist/
DAT Inhibitors

Programs

bottom of page